Iovance Biotherapeutics, Inc. (IOVA)
2.25
+0.09
(+4.17%)
USD |
NASDAQ |
Dec 16, 16:00
2.24
-0.01
(-0.44%)
After-Hours: 20:00
Iovance Biotherapeutics Research and Development Expense (Annual): 282.34M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Lantheus Holdings, Inc. | 168.10M |
| Day One Biopharmaceuticals, Inc. | 227.70M |
| Travere Therapeutics, Inc. | 217.50M |
| Xenetic Biosciences, Inc. | 2.584M |
| KalVista Pharmaceuticals, Inc. | 76.72M |